Effect of ertugliflozin on left ventricular function in type 2 diabetes and pre-heart failure: the Ertu-GLS randomized clinical trial
Abstract Background The therapeutic effects of ertugliflozin, a sodium-glucose cotransporter 2 inhibitor, on cardiovascular outcome are not fully understood. This study aimed to evaluate the efficacy and safety of ertugliflozin on cardiac function in people with type 2 diabetes and pre-heart failure...
| 出版年: | Cardiovascular Diabetology |
|---|---|
| 主要な著者: | Soo Lim, Jae Hyun Bae, Heran Oh, In-Chang Hwang, Yeonyee E. Yoon, Goo-Yeong Cho |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMC
2024-10-01
|
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s12933-024-02463-0 |
類似資料
Effectiveness of ertugliflozin during Ramadan fasting in patients with type 2 diabetes mellitus: a real-world study (ErtuRamadan study)
著者:: Md Faruque Pathan, 等
出版事項: (2025-02-01)
著者:: Md Faruque Pathan, 等
出版事項: (2025-02-01)
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure
著者:: Yuliya Lytvyn, 等
出版事項: (2025-04-01)
著者:: Yuliya Lytvyn, 等
出版事項: (2025-04-01)
Effect of olmesartan and amlodipine on serum angiotensin-(1–7) levels and kidney and vascular function in patients with type 2 diabetes and hypertension
著者:: Kyuho Kim, 等
出版事項: (2023-03-01)
著者:: Kyuho Kim, 等
出版事項: (2023-03-01)
Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm
著者:: Sunitha Gurrala, 等
出版事項: (2023-06-01)
著者:: Sunitha Gurrala, 等
出版事項: (2023-06-01)
The role of the classical renin–angiotensin system and angiotensin-converting enzyme 2/Ang(1–7)/Mas axis in pulmonary fibrosis
著者:: Changhui Lang, 等
出版事項: (2025-07-01)
著者:: Changhui Lang, 等
出版事項: (2025-07-01)
Renin-Angiotensin System: A Review of Historical Perspectives
著者:: Olga Kovalyova, 等
出版事項: (2023-05-01)
著者:: Olga Kovalyova, 等
出版事項: (2023-05-01)
Myocardial and Renal Renin–Angiotensin System Enzyme Activity in Dogs
著者:: Emma C. Weitzhandler, 等
出版事項: (2025-07-01)
著者:: Emma C. Weitzhandler, 等
出版事項: (2025-07-01)
The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences
著者:: Minela Aida Maranduca, 等
出版事項: (2022-09-01)
著者:: Minela Aida Maranduca, 等
出版事項: (2022-09-01)
The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus
著者:: O. K. Vikulova, 等
出版事項: (2020-08-01)
著者:: O. K. Vikulova, 等
出版事項: (2020-08-01)
New SGLT2 inhibitor ertugliflozin: safe and effective in the management of type 2 diabetes
著者:: V. V. Salukho, 等
出版事項: (2020-05-01)
著者:: V. V. Salukho, 等
出版事項: (2020-05-01)
Angiotensin-Related Peptides and Their Role in Pain Regulation
著者:: Wataru Nemoto, 等
出版事項: (2023-05-01)
著者:: Wataru Nemoto, 等
出版事項: (2023-05-01)
Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan
著者:: Antônio Carlos Avanza Jr, 等
出版事項: (2000-02-01)
著者:: Antônio Carlos Avanza Jr, 等
出版事項: (2000-02-01)
From gene to protein - experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
著者:: Sheila K Patel, 等
出版事項: (2014-06-01)
著者:: Sheila K Patel, 等
出版事項: (2014-06-01)
Evaluation of the Association between Multilobar Involvement and ACE Inhibitor Use in SARS-CoV-2 Patients
著者:: Dilay Satilmis, 等
出版事項: (2023-01-01)
著者:: Dilay Satilmis, 等
出版事項: (2023-01-01)
The Effect of Hydroalcoholic Seed Extract of Securigera Securidaca on the Hepatic Renin-Angiotensin System in the Streptozotocin-Induced Diabetic Animal Model
著者:: Bahar Kiani, 等
出版事項: (2022-04-01)
著者:: Bahar Kiani, 等
出版事項: (2022-04-01)
Differential Roles of Angiotensin A and Alamandine in Parkinson's Disease: A Therapeutic Perspective on Nonclassical RAS Pathways
著者:: Ghadah H. Alshehri, 等
出版事項: (2025-08-01)
著者:: Ghadah H. Alshehri, 等
出版事項: (2025-08-01)
Angiotensin II and COVID-19. Secrets of interactions
著者:: A. O. Konradi, 等
出版事項: (2020-05-01)
著者:: A. O. Konradi, 等
出版事項: (2020-05-01)
Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
著者:: Daniel eClayton, 等
出版事項: (2015-01-01)
著者:: Daniel eClayton, 等
出版事項: (2015-01-01)
Ertugliflozin, a SGLT-2 Inhibitor, Guards Against Thioacetamide-induced Liver Fibrosis: The Nrf2/HO-1 and TLR4/ TGF-β1 Pathways
著者:: Nourhan Hassan, 等
出版事項: (2025-07-01)
著者:: Nourhan Hassan, 等
出版事項: (2025-07-01)
Evaluation of myocardial classic and alternative pathways of the renin-angiotensin system in cholestasis-induced cardiac injury: A time-course experimental study in rats
著者:: Azadeh Khalili, 等
出版事項: (2025-11-01)
著者:: Azadeh Khalili, 等
出版事項: (2025-11-01)
2019 novel-coronavirus: Cardiovascular insights about risk factors, myocardial injury, therapy and clinical implications
著者:: Luigi Cappannoli, 等
出版事項: (2020-12-01)
著者:: Luigi Cappannoli, 等
出版事項: (2020-12-01)
Why not change the therapy of hypertension in patients with COVID-19. Dual role of angiotensin-converting enzyme 2
著者:: Jerzy Głuszek, 等
出版事項: (2022-03-01)
著者:: Jerzy Głuszek, 等
出版事項: (2022-03-01)
Investigating the Relationship Between High Levels of Angiotensin II in Plasma and the Rate of Deterioration in Hypertensive Patients to COVID-19
著者:: Mina Shahnazari, 等
出版事項: (2023-03-01)
著者:: Mina Shahnazari, 等
出版事項: (2023-03-01)
Comparative effect of ARNI and ACEI/ARB on left ventricular diastolic function in patients with hypertensive heart disease
著者:: YANG Hao, 等
出版事項: (2025-06-01)
著者:: YANG Hao, 等
出版事項: (2025-06-01)
Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
著者:: O. M. Drapkina, 等
出版事項: (2020-07-01)
著者:: O. M. Drapkina, 等
出版事項: (2020-07-01)
Correlation between orthostatic intolerance in children and levels of ACE2-Ang(1-7)-Mas axis and vitamin D
著者:: Yao Xiao, 等
出版事項: (2025-05-01)
著者:: Yao Xiao, 等
出版事項: (2025-05-01)
ACE2 Regulates Glycolipid Metabolism in Multiple Tissues
著者:: Rui Li, 等
出版事項: (2024-01-01)
著者:: Rui Li, 等
出版事項: (2024-01-01)
Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease
著者:: Éva Larouche‐Lebel, 等
出版事項: (2021-01-01)
著者:: Éva Larouche‐Lebel, 等
出版事項: (2021-01-01)
Bibliometric and visual analysis of ACE2/Ang 1–7/MasR axis in diabetes and its microvascular complications from 2000 to 2023
著者:: Weiwen Hu, 等
出版事項: (2024-05-01)
著者:: Weiwen Hu, 等
出版事項: (2024-05-01)
ACE2 Alleviates Endoplasmic Reticulum Stress and Protects against Pyroptosis by Regulating Ang1-7/Mas in Ventilator-Induced Lung Injury
著者:: Xingsheng Lin, 等
出版事項: (2024-09-01)
著者:: Xingsheng Lin, 等
出版事項: (2024-09-01)
Progress of angiotensin converting enzyme 2 in cardiovascular diseases
著者:: JIAO Xiao-lu, QIN Yan-wen
出版事項: (2020-05-01)
著者:: JIAO Xiao-lu, QIN Yan-wen
出版事項: (2020-05-01)
The prevalence and role of functional autoantibodies to angiotensin-converting-enzyme-2 in patients with systemic sclerosis
著者:: Bartosz Miziołek, 等
出版事項: (2021-05-01)
著者:: Bartosz Miziołek, 等
出版事項: (2021-05-01)
Urinary Angiotensin Converting Enzyme 2 Increases in Patients With Type 2 Diabetic Mellitus
著者:: Yaoxian Liang, 等
出版事項: (2015-03-01)
著者:: Yaoxian Liang, 等
出版事項: (2015-03-01)
Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19
著者:: Naci Şenkal, 等
出版事項: (2020-07-01)
著者:: Naci Şenkal, 等
出版事項: (2020-07-01)
Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases
著者:: Aditi D. Kunvariya, 等
出版事項: (2023-05-01)
著者:: Aditi D. Kunvariya, 等
出版事項: (2023-05-01)
Patients with severe COVID‐19 have reduced circulating levels of angiotensin‐(1–7): A cohort study
著者:: Seyed Mohammad Seyedmehdi, 等
出版事項: (2022-03-01)
著者:: Seyed Mohammad Seyedmehdi, 等
出版事項: (2022-03-01)
Circulating Soluble ACE2 Plays an Independent Role to Protect against Vascular Damage in Diabetic Mice
著者:: Chris Tikellis, 等
出版事項: (2022-05-01)
著者:: Chris Tikellis, 等
出版事項: (2022-05-01)
Exploring the implications of blocking renin-angiotensin-aldosterone system and fibroblast growth factor 23 in early left ventricular hypertrophy without chronic kidney disease
著者:: Kentaro Watanabe, 等
出版事項: (2023-12-01)
著者:: Kentaro Watanabe, 等
出版事項: (2023-12-01)
Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2
著者:: John M. Matsoukas, 等
出版事項: (2022-07-01)
著者:: John M. Matsoukas, 等
出版事項: (2022-07-01)
RENIN-ANGIOTENSIN SYSTEM IN REGULATION OF HEMATOPOIESIS
著者:: M. L. Kanaeva, 等
出版事項: (2018-02-01)
著者:: M. L. Kanaeva, 等
出版事項: (2018-02-01)
類似資料
-
Effectiveness of ertugliflozin during Ramadan fasting in patients with type 2 diabetes mellitus: a real-world study (ErtuRamadan study)
著者:: Md Faruque Pathan, 等
出版事項: (2025-02-01) -
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure
著者:: Yuliya Lytvyn, 等
出版事項: (2025-04-01) -
Effect of olmesartan and amlodipine on serum angiotensin-(1–7) levels and kidney and vascular function in patients with type 2 diabetes and hypertension
著者:: Kyuho Kim, 等
出版事項: (2023-03-01) -
Chromatographic study of sitagliptin and ertugliflozin under quality-by-design paradigm
著者:: Sunitha Gurrala, 等
出版事項: (2023-06-01) -
The role of the classical renin–angiotensin system and angiotensin-converting enzyme 2/Ang(1–7)/Mas axis in pulmonary fibrosis
著者:: Changhui Lang, 等
出版事項: (2025-07-01)